SCHEMBL56962

SCHEMBL56962

CCC(OP(=O)(CCC(C(=O)OCc1ccccc1)N(C=O)OCc1ccccc1)Oc1ccccc1)C(=O)NCC(=O)OCc1ccccc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.39
CYP3A4 P08684 1/20 0.39
CYP2D6 P10635 1/20 0.39
CYP2C9 P11712 1/20 0.39
CYP2C19 P33261 1/20 0.39
ABCC3 O15438 1/20 0.39
NR1I2 O75469 1/20 0.39
ABCB11 O95342 1/20 0.39
NR3C1 P04150 1/20 0.39
RARG P13631 1/20 0.39
CNR1 P21554 1/20 0.39
OPRK1 P41145 1/20 0.39
NR1H2 P55055 1/20 0.39
PPARA Q07869 1/20 0.39
NR1H3 Q13133 1/20 0.39
NR1I3 Q14994 1/20 0.39
KMT2A Q03164 2/20 0.38
PRTN3 P24158 2/20 0.36
ELANE P08246 2/20 0.35
MEN1 O00255 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL56963 0.81 PRTN3 (0.46) CYP1A2CYP3A4CYP2D6CYP2C9CYP2C19
SCHEMBL57019 0.79 PRTN3 (0.39) CYP3A4PRTN3ELANEL3MBTL1ALDH1A1
SCHEMBL56935 0.78 ALDH1A1 (0.41) PPARAPRTN3ELANEL3MBTL1SMN1; SMN2
SCHEMBL57115 0.78 ATM (0.39) KMT2APRTN3ELANEMEN1GAA
SCHEMBL56408 0.77 BTN3A1 (0.37) CYP2C19KMT2APRTN3ELANEMEN1
SCHEMBL57868 0.77 L3MBTL1 (0.37) PRTN3ELANEL3MBTL1ALDH1A1BTN3A1
SCHEMBL56466 0.76 TP53 (0.41) PPARAKMT2APRTN3ELANEMEN1
SCHEMBL56920 0.76 MMP2 (0.37) PPARAPRTN3ELANEBTN3A1
SCHEMBL56887 0.75 L3MBTL1 (0.34) CYP2D6PRTN3ELANEL3MBTL1GAA
SCHEMBL57135 0.75 MAPT (0.41) KMT2APRTN3ELANEL3MBTL1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8129557-B2 Phosphonic acid diester derivative and method for producing thereof Nagai, Kazuhiro (JP) 2012-03-06 US disclosed
US-20090163725-A1 PHOSPHONIC ACID DIESTER DERIVATIVE AND METHOD FOR PRODUCING THEREOF HIRATAKE, GOU (JP) 2009-06-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090163725-A1 PHOSPHONIC ACID DIESTER DERIVATIVE AND METHOD FOR PRODUCING THEREOF PPA1, G6PD, PHOSPHO1 CYP1A2 1147/4885CYP3A4 1774/4885CYP2D6 994/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.